Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.04 USD | -19.95% | +38.81% | -54.86% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.86% | 5.62M | |
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |
- Stock Market
- Equities
- EIGR Stock
- News Eiger BioPharmaceuticals, Inc.
- Eiger BioPharmaceuticals Phase 3 Lonafarnib-Based Treatments Achieve Statistical Significance